GlassScriptPhysician profile
Christopher C Dankmyer
NPI 1801810247
$7,272.99
in general payments reported to CMS, 2019-2025
54 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $842 · 2021: $508 · 2022: $903 · 2023: $1,852 · 2024: $1,377 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,394.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $814.15 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $680.99 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Scilex Pharmaceuticals INC. | $626.55 | 2022-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $584.78 | 2022-2025 | Belbuca, Xtampza |
| Averitas Pharma INC. | $471.30 | 2023-2025 | Qutenza |
| Mdd US Operations, LLC | $318.71 | 2019-2020 | |
| Mml US, INC. | $296.86 | 2024 | Reactiv8 |
| Ipsen Biopharmaceuticals, INC | $293.31 | 2019-2025 | Dysport |
| Boston Scientific Corporation | $268.14 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Biodelivery Sciences International, INC. | $216.09 | 2019-2021 | |
| Tersera Therapeutics LLC | $210.49 | 2021-2025 | Prialt |
| Nevro Corp. | $192.52 | 2023 | Senza |
| Foundation Fusion Solutions, LLC | $185.10 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $161.74 | 2024-2025 | Euflexxa |
| Abbott Laboratories | $160.17 | 2022-2025 | Proclaim, Octrode, Eterna |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dankmyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.